Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Dec;5(4):373-4.
doi: 10.1007/BF00169977.

Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma

S Martino  1 , D A Decker, H E Hynes, C L Kresge
Affiliations

Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma

S Martino et al. Invest New Drugs. 1987 Dec.

Abstract

Sixteen women with advanced epithelial ovarian carcinoma were treated with Aclacinomycin-A 40 mg/M2 given as a weekly infusion for four consecutive weeks followed by a two week rest period. All had failed prior chemotherapy. No responses were observed. Nausea and vomiting were the most frequent side effect. Myelosuppression was minimal. This dose and schedule of Aclacinomycin-A are not recommended for further trials in ovarian carcinoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Invest New Drugs. 1983;1(2):173-9 - PubMed
    1. Gan. 1977 Oct;68(5):685-90 - PubMed
    1. Biomed Pharmacother. 1984;38(7):332-7 - PubMed
    1. Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1127-8 - PubMed
    1. J Antibiot (Tokyo). 1975 Oct;28(10 ):830-4 - PubMed

Publication types

LinkOut - more resources